Brandon Capital raises $180M fund to support Australia, New Zealand biotechs

The Australian and New Zealand life sciences sector will get a nice boost from a new A$270 million ($180 million) fund from venture capital firm Brandon Capital.

Money from the Brandon Capital Fund VI is being earmarked for life sciences start-ups in the region, particularly early-stage companies, according to a Tuesday press release. The funds will help propel companies through the early growth stages.